Founders

celler

Founder, CEO Mai-Britt Zocca, PhD

Experienced biotech executive (15+y) having worked in a number of start-ups with significant insight in to translational and clinical immune oncology.

Founder, CSO and member of BoD, Professor Mads Hald Andersen

Professor and Director of CCIT (Center for Cancer Immune Therapy at Herlev University Hospital. Mads Hald Andersen has received several honors for his scientific work and is the author of more than 130 papers. MHA has founded and co-founded several spin out companies with a successful sale of Survac in 2006.

Founder and CMC, Anders Ljungqvist

Extensive experience (35+ y) in pharmaceutical development, including Regulatory Affairs and Quality Assurance, having held executive positions in pharma-, biotech- and consultancy companies.

Founder, Clinical Advisor, Professor MD PhD Inge Marie Svane.

Professor and Director of CCIT (Center for Cancer Immune Therapy at Herlev University Hospital. IMS has extensive experience in clinical translation of immune therapies and is an advisor for several large pharma companies. Currently running a phase III trial.

Founder, Professor Per Thor Straten

Professor and Director of CCIT (Center for Cancer Immune Therapy at Herlev University Hospital. Peter Thor Straten has founded and co-founded several spin out companies with a successful sale of Survac in 2003.